Skip to main content

PHARM · Pharming Group N.V. · Debt

0.8640 EUR 15-min delayed · Oct 6, 14:59 UTC

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current bonds issued, including current portion of noncurrent bonds 2025-12-31 USD 5,336,000 20-F/A filed 2026-04-13
Lease liabilities 2025-12-31 USD 17,719,000 20-F/A filed 2026-04-13
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current lease liabilities
USD 3,369,000
Noncurrent lease liabilities
USD 14,351,000
Noncurrent bonds issued 2025-12-31 USD 92,719,000 20-F/A filed 2026-04-13
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.